MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease

Clinical trial NCT06788340 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06788340
Sponsor: Odense University Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis

Start date: 2025-09-01
Primary completion: 2027-08-30
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.